Iranian Red Crescent Medical Journal

Published by: Kowsar

No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population

Mohammad Reza Eslami Amirabadi 1 , Rozita Davari-Ashtiani 3 , Mojgan Khademi 3 , Sepideh RajeziEsfahani 1 , Babak Emamalizadeh 2 , Abolfazl Movafagh 2 , Fariba Arabgol 3 , Said Sadr 3 , Hossein Darvish 2 , * and Katayoon Razjouyan 3 , *
Authors Information
1 Behavioral Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Psychiatry, Imam Hosein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Corresponding Authors:
Article information
  • Iranian Red Crescent Medical Journal: July 01, 2015, 17 (7); e22996
  • Published Online: July 23, 2015
  • Article Type: Research Article
  • Received: August 25, 2014
  • Revised: September 9, 2014
  • Accepted: November 9, 2014
  • DOI: 10.5812/ircmj.229961v2

To Cite: Eslami Amirabadi M R, Davari-Ashtiani R, Khademi M, RajeziEsfahani S, Emamalizadeh B, et al. No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population, Iran Red Crescent Med J. 2015 ; 17(7):e22996. doi: 10.5812/ircmj.229961v2.

Copyright © 2015, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Diagnostic and statistical manual-text revision (DSM-IV-TRim, 2000). 2000;
  • 2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007; 164(6): 942-8[DOI][PubMed]
  • 3. Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Retard Dev Disabil Res Rev. 2002; 8(3): 162-70[DOI][PubMed]
  • 4. Waldman ID, Rhee SH. Hyperactivity and attention disorders of childhood. 2002; : 290-335
  • 5. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(11): 1313-23[DOI][PubMed]
  • 6. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006; 11(10): 934-53[DOI][PubMed]
  • 7. Schimmelmann BG, Friedel S, Christiansen H, Dempfle A, Hinney A, Hebebrand J. [Genetic findings in Attention-Deficit and Hyperactivity Disorder (ADHD)]. Z Kinder Jugendpsychiatr Psychother. 2006; 34(6): 425-33[DOI][PubMed]
  • 8. Albayrak O, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J. Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm. 2008; 115(2): 305-15[DOI][PubMed]
  • 9. Gamo NJ, Wang M, Arnsten AF. Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry. 2010; 49(10): 1011-23[DOI][PubMed]
  • 10. Vikas M, Chandrasekaran R. A case of obsessive-compulsive disorder by proxy. Gen Hosp Psychiatry. 2011; 33(3): 303 e5-6[DOI][PubMed]
  • 11. Seneca N, Gulyas B, Varrone A, Schou M, Airaksinen A, Tauscher J, et al. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. Psychopharmacology (Berl). 2006; 188(1): 119-27[DOI][PubMed]
  • 12. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet. 2005; 134B(1): 67-72[DOI][PubMed]
  • 13. Kim BN, Kim JW, Hong SB, Cho SC, Shin MS, Yoo HJ. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder. Behav Brain Funct. 2010; 6: 57[DOI][PubMed]
  • 14. Kim JW, Biederman J, McGrath CL, Doyle AE, Mick E, Fagerness J, et al. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD. Mol Psychiatry. 2008; 13(6): 624-30[DOI][PubMed]
  • 15. Retz W, Rosler M, Kissling C, Wiemann S, Hunnerkopf R, Coogan A, et al. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J Neural Transm. 2008; 115(2): 323-9[DOI][PubMed]
  • 16. Joung Y, Kim CH, Moon J, Jang WS, Yang J, Shin D, et al. Association studies of− 3081 (A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2010; 153(2): 691-4
  • 17. Xu X, Knight J, Brookes K, Mill J, Sham P, Craig I, et al. DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association. Am J Med Genet B Neuropsychiatr Genet. 2005; 134B(1): 115-8[DOI][PubMed]
  • 18. Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, Maller JB, et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(8): 1345-54[DOI][PubMed]
  • 19. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, et al. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci U S A. 2006; 103(50): 19164-9[DOI][PubMed]
  • 20. Bauermeister JJ, Shrout PE, Chavez L, Rubio-Stipec M, Ramirez R, Padilla L, et al. ADHD and gender: are risks and sequela of ADHD the same for boys and girls? J Child Psychol Psychiatry. 2007; 48(8): 831-9[DOI][PubMed]
  • 21. Nezu A, Nezu C. A practical guide to conducting randomized controlled trials for psychosocial interventions. 2008;
  • 22. Hummer TA, Kronenberger WG, Wang Y, Dunn DW, Mosier KM, Kalnin AJ, et al. Executive functioning characteristics associated with ADHD comorbidity in adolescents with disruptive behavior disorders. J Abnorm Child Psychol. 2011; 39(1): 11-9[DOI][PubMed]
  • 23. Rosler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, et al. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci. 2004; 254(6): 365-71[DOI][PubMed]
  • 24. Brook U, Boaz M. Attention deficit and hyperactivity disorder (ADHD) and learning disabilities (LD): adolescents perspective. Patient Educ Couns. 2005; 58(2): 187-91[DOI][PubMed]
  • 25. Nikolas MA, Burt SA. Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis. J Abnorm Psychol. 2010; 119(1): 1-17[DOI][PubMed]
  • 26. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009; 126(1): 51-90[DOI][PubMed]
  • 27. Barr CL, Kroft J, Feng Y, Wigg K, Roberts W, Malone M, et al. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am J Med Genet. 2002; 114(3): 255-9[PubMed]
  • 28. McEvoy B, Hawi Z, Fitzgerald M, Gill M. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am J Med Genet. 2002; 114(6): 665-6[DOI][PubMed]
  • 29. Guan L, Wang B, Chen Y, Yang L, Li J, Qian Q, et al. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry. 2009; 14(5): 546-54[DOI][PubMed]
  • 30. Biederman J, Kim JW, Doyle AE, Mick E, Fagerness J, Smoller JW, et al. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(8): 1511-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments